Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
510,430
Value
$253.5M
% of portfolio
0.1%
Quarters held
21
Since Q1 2021
Holdings of VRTX by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026510,430$253.5M0.1%+171,132+50.4%AddedHolders
Q1 2026339,298$151.5M0.1%−87,762−20.6%ReducedHolders
Q4 2025427,060$193.6M0.1%+253,558+146.1%AddedHolders
Q3 2025173,502$68.0M0.1%+144,675+501.9%AddedHolders
Q2 202528,827$12.8M<0.1%+23,808+474.4%AddedHolders
Q1 20255,019$2.43M<0.1%−157,162−96.9%ReducedHolders
Q4 2024162,181$65.3M0.1%+111,949+222.9%AddedHolders
Q3 202450,232$23.4M<0.1%−54,363−52.0%ReducedHolders
Q2 2024104,595$49.0M<0.1%+22,622+27.6%AddedHolders
Q1 202481,973$34.3M<0.1%−244,707−74.9%ReducedHolders
Q4 2023326,680$132.9M0.1%+298,936+1,077.5%AddedHolders
Q3 202327,744$9.65M<0.1%+27,631+24,452.2%AddedHolders
Q2 2023113$39.8K<0.1%−83,693−99.9%ReducedHolders
Q1 202383,806$26.4M<0.1%−119,805−58.8%ReducedHolders
Q4 2022203,611$58.8M0.1%+189,846+1,379.2%AddedHolders
Q3 202213,765$3.99M<0.1%+13,765NewHolders
Q2 20220$00.0%−42,605−100.0%Sold outHolders
Q1 202242,605$11.1M<0.1%−209,986−83.1%ReducedHolders
Q4 2021252,591$55.5M0.1%−161,538−39.0%ReducedHolders
Q3 2021414,129$75.1M0.1%+24,539+6.3%AddedHolders
Q2 2021389,590$78.6M0.1%−1,329,590−77.3%ReducedHolders
Q1 20211,719,180$369.4M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.